Assistant Professor in Medicine-Hematology/Oncology, Northwestern University Medical School
Hematology
Dr. Olga Frankfurt, MD
|
|
Give Review
Olga Frankfurt is an expert in the field of Hematology. She went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care She has 1 awards "Meaningful Use Stage 1 Certification". Dr. Olga Frankfurt is a published doctor. She published 24 publications, including: 'Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients.' She accepts Medicare.
Publications
- Real-time qPCR for chimerism assessment in allogeneic hematopoietic stem cell transplants from unrelated adult and double umbilical cord blood.
- Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic Leukemia: short- and long-term outcomes.
- F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lym...
- Ponatinib--a step forward in overcoming resistance in chronic myeloid Leukemia.
- Demodex Folliculitis Mimicking Acute Graft-vs-Host Disease.
- Administration of ATRA to newly diagnosed patients with Acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.
- Dose-intense etoposide-cyclophosphamide without stem cell transplantation for patients with intermediate and high cytogenetic risk primary refractory and relapsed acut...
- Implications of lipocalin 2 expression in Acute myeloid leukemia.
- Philadelphia chromosome positive Acute myeloid leukemia or de novo chronic myeloid leukemia-blast phase?
- Non-tyrosine kinase inhibitor-targeting of BCR-ABL expressing cells.
- Enzyme-linked immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening.
- Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic Leukemia patients.
- Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed Acute myeloid leukemia.
- Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic Leukemia.
- The hematopoietic growth factors in Acute leukemia: U.S. perspective.
- Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.
- The coagulopathy of Acute promyelocytic leukaemia revisited.
- A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell Lymphoma.
- Molecular characterization of Acute myeloid leukemia and its impact on treatment.
- Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
- Growth factors in Leukemia.
- Strategies for the treatment of Acute promyelocytic leukemia.
- Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates.
Schools
University of Chicago
Rush Presby St Luke39s M C
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
McGaw Medical Center of Northwestern University -
Rush University Medical Center -
University of Chicago Pritzker School of Medicine
Hospital
-
Northwestern Memorial Hospital -
Lurie Children's Hospital of Chicago
Drug Facts
| NPI NUMBER | 1962492611 | |
| NPPES Provider LastName | FRANKFURT | |
| NPPES Provider FirstName | OLGA | |
| NPPES Provider ZIPCode | 606115975 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology | |
| Total Claim Count | 626.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962492611 |
| Last Name Of The Provider | FRANKFURT |
| First Name Of The Provider | OLGA |
| View All |
Similar Doctors
|
Dr. Pawan Gundavaram, MD |
|
|
Dr. John M. Raba, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane Winter, MD |
|
Dr. Irfan A. Mirza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven A. Sandler, MD |
|
|
Dr. Elizabeth A. Eklund, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Neeta K. Venepalli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yi Hua Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Maitland, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jayesh Mehta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lili Wang, MD |
|
|
Dr. Manish Sharma, MD |
|
|
Dr. Nirav N. Shah, MD |
|
|
Dr. Salman A. Waheed, MD |
|
|
Dr. Jukes P. Namm, MD |
|
|
Dr. Benjamin T. Toh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Josette W. Ragheb, MB CHB |